TP53 and breast carcinoma: These results are in agreement with our recent study showing that salinomycin significantly decreased viability of the wild-type p53 MCF-7 and T47D as well as mutant p53 MDA-MB-231 and T47D human breast cancer cell lines in time- and concentration-dependent manners [21].